Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma

NCT07748988 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Refractory Clear Cell Renal Cell Carcinoma
Metastatic Clear Cell Renal Cell Carcinoma

Interventions

DRUG: casdatifan

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]